BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34642351)

  • 1. Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms.
    Huang CH; Hung PL; Fan PC; Lin KL; Hsu TR; Chou IJ; Ho CS; Chou IC; Lin WS; Lee IC; Fan HC; Chen SJ; Liang JS; Tu YF; Chang TM; Hu SC; Wong LC; Hung KL; Lee WT
    Sci Rep; 2021 Oct; 11(1):20242. PubMed ID: 34642351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior problems and health-related quality of life in Dravet syndrome.
    Sinoo C; de Lange IM; Westers P; Gunning WB; Jongmans MJ; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():217-227. PubMed ID: 30578097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.
    LoPresti M; Igarashi A; Sonohara Y; Bowditch S
    Epilepsy Behav; 2024 May; 154():109741. PubMed ID: 38555725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany.
    Maltseva M; Schubert-Bast S; Zöllner JP; Bast T; Mayer T; von Spiczak S; Ruf S; Trollmann R; Wolff M; Hornemann F; Klotz KA; Jacobs J; Kurlemann G; Neubauer BA; Polster T; Syrbe S; Bertsche A; Bettendorf U; Kluger G; Flege S; Rosenow F; Kay L; Strzelczyk A
    Orphanet J Rare Dis; 2023 Apr; 18(1):98. PubMed ID: 37120555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dravet syndrome: Characteristics, comorbidities, and caregiver concerns.
    Villas N; Meskis MA; Goodliffe S
    Epilepsy Behav; 2017 Sep; 74():81-86. PubMed ID: 28732259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey.
    Campbell JD; Whittington MD; Kim CH; VanderVeen GR; Knupp KG; Gammaitoni A
    Epilepsy Behav; 2018 Mar; 80():152-156. PubMed ID: 29414545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?
    Verbeek NE; Wassenaar M; van Campen JS; Sonsma A; Gunning B; Knoers N; Lindhout D; Jansen FE; Leijten F; Brilstra EH; Kasteleijn-Nolst Trenité D
    Epilepsy Behav; 2015 Jun; 47():39-44. PubMed ID: 26021464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities and predictors of health-related quality of life in Dravet syndrome: A 10-year, prospective follow-up study.
    Makiello P; Feng T; Dunwoody B; Steckler F; Symonds J; Zuberi SM; Dorris L; Brunklaus A
    Epilepsia; 2023 Apr; 64(4):1012-1020. PubMed ID: 36740581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pharmacological therapeutic needs in people with Dravet syndrome.
    Ballesteros-Sayas C; Muñoz-Montero A; Giorgi S; Cardenal-Muñoz E; Turón-Viñas E; Pallardó F; Aibar JÁ
    Epilepsy Behav; 2024 Jan; 150():109553. PubMed ID: 38035538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular aspects of Dravet syndrome patients in Taiwan.
    Lin WD; Chang KP; Wang CH; Chen SJ; Fan PC; Weng WC; Lin WC; Tsai Y; Tsai CH; Chou IC; Tsai FJ
    Clin Chim Acta; 2013 Jun; 421():34-40. PubMed ID: 23485646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany.
    Strzelczyk A; Schubert-Bast S; Bast T; Bettendorf U; Fiedler B; Hamer HM; Herting A; Kalski M; Kay L; Kieslich M; Klein KM; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; von Spiczak S; Stephani U; Trollmann R; Wiemer-Kruel A; Wolff M; Irwin J; Carroll J; Pritchard C; Rosenow F
    Epilepsia; 2019 Aug; 60(8):1697-1710. PubMed ID: 31247127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study.
    Lagae L; Irwin J; Gibson E; Battersby A
    Seizure; 2019 Feb; 65():72-79. PubMed ID: 30616222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers.
    Nabbout R; Dirani M; Teng T; Bianic F; Martin M; Holland R; Chemaly N; Coque N
    Epilepsy Behav; 2020 Jul; 108():107094. PubMed ID: 32375095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research.
    Jensen MP; Brunklaus A; Dorris L; Zuberi SM; Knupp KG; Galer BS; Gammaitoni AR
    Epilepsy Behav; 2017 May; 70(Pt A):104-109. PubMed ID: 28431364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional experiences of family caregivers of children with Dravet syndrome.
    Domaradzki J; Walkowiak D
    Epilepsy Behav; 2023 May; 142():109193. PubMed ID: 37028149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental Perception of Comorbidities in Children With Dravet Syndrome.
    Knupp KG; Scarbro S; Wilkening G; Juarez-Colunga E; Kempe A; Dempsey A
    Pediatr Neurol; 2017 Nov; 76():60-65. PubMed ID: 28982531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of EEG-fMRI findings in patients with SCN1A-positive Dravet syndrome.
    Moehring J; von Spiczak S; Moeller F; Helbig I; Wolff S; Jansen O; Muhle H; Boor R; Stephani U; Siniatchkin M
    Epilepsia; 2013 May; 54(5):918-26. PubMed ID: 23398550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.